ProPhase Labs (PRPH) News Today → The Best AI Stock to Own in the World Today is Trading for Just $25 (From Banyan Hill Publishing) (Ad) Free PRPH Stock Alerts $5.14 +0.07 (+1.38%) (As of 05/15/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 15 at 7:15 PM | seekingalpha.comProPhase Labs: Hidden Gem With An AI KickerMay 15 at 1:44 AM | americanbankingnews.comProPhase Labs (NASDAQ:PRPH) Lifted to Sell at StockNews.comMay 10, 2024 | marketbeat.comProPhase Labs (NASDAQ:PRPH) Announces Quarterly Earnings Results, Beats Expectations By $0.21 EPSProPhase Labs (NASDAQ:PRPH - Get Free Report) released its quarterly earnings data on Thursday. The company reported ($0.07) EPS for the quarter, beating the consensus estimate of ($0.28) by $0.21. The company had revenue of $3.63 million for the quarter, compared to analysts' expectations of $9.86 million. ProPhase Labs had a negative return on equity of 29.83% and a negative net margin of 37.81%. During the same period last year, the firm posted $0.03 earnings per share.May 9, 2024 | globenewswire.comProPhase Labs Announces Financial Results for the Three Months Ended March 31, 2024, and Highlights Significant Progress in its Strategic Initiatives. - UpdatedMay 9, 2024 | finance.yahoo.comProPhase Labs Announces Financial Results for the Three Months Ended March 31, 2024, and Highlights Significant Progress in its Strategic Initiatives.May 9, 2024 | americanbankingnews.comAgile Therapeutics (NASDAQ:AGRX) and ProPhase Labs (NASDAQ:PRPH) Critical ContrastMay 8, 2024 | americanbankingnews.comProPhase Labs (PRPH) to Release Earnings on ThursdayMay 3, 2024 | marketbeat.comProPhase Labs (PRPH) Set to Announce Earnings on ThursdayProPhase Labs (NASDAQ:PRPH) will be releasing earnings before the market opens on Thursday, May 9, Zacks reports.May 2, 2024 | finance.yahoo.comPROPHASE LABS INC. TO PRESENT FIRST QUARTER 2024 FINANCIAL RESULTS ON MAY 9May 2, 2024 | finance.yahoo.comPROPHASE LABS INC. TO PRESENT FIRST QUARTER 2024 FINANCIAL RESULTS ON MAY 9April 25, 2024 | globenewswire.comProPhase Labs to Present at the Planet MicroCap Showcase: VEGAS 2024 on Wednesday, May 1, 2024 & 1x1 Meetings on Thursday, May 2, 2024April 25, 2024 | marketbeat.comDiamond Equity Equities Analysts Cut Earnings Estimates for ProPhase Labs, Inc. (NASDAQ:PRPH)ProPhase Labs, Inc. (NASDAQ:PRPH - Free Report) - Stock analysts at Diamond Equity dropped their Q1 2024 EPS estimates for ProPhase Labs in a note issued to investors on Monday, April 22nd. Diamond Equity analyst H. Diamond now forecasts that the company will post earnings per share of ($0.15) foApril 24, 2024 | marketbeat.comEquities Analysts Set Expectations for ProPhase Labs, Inc.'s Q1 2025 Earnings (NASDAQ:PRPH)ProPhase Labs, Inc. (NASDAQ:PRPH - Free Report) - Investment analysts at Diamond Equity issued their Q1 2025 earnings per share (EPS) estimates for ProPhase Labs in a report issued on Monday, April 22nd. Diamond Equity analyst H. Diamond forecasts that the company will post earnings per share ofApril 16, 2024 | marketwatch.comProPhase Labs Shares Jump on New AI-Based ProjectApril 16, 2024 | globenewswire.comProPhase Labs Unveils Project ZenQ-AIApril 10, 2024 | finanznachrichten.deProPhase Labs, Inc.: ProPhase Labs Seeks to Transform Esophageal Cancer Detection and Management with Launch of its BE-Smart Test in H2 2024April 10, 2024 | baystreet.caProPhase Flat on Cancer Drug ProgressApril 10, 2024 | globenewswire.comProPhase Labs Seeks to Transform Esophageal Cancer Detection and Management with Launch of its BE-Smart Test in H2 2024April 1, 2024 | globenewswire.comProPhase Labs Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)April 1, 2024 | finance.yahoo.comProPhase Labs, Inc. (PRPH)March 30, 2024 | marketbeat.comShort Interest in ProPhase Labs, Inc. (NASDAQ:PRPH) Declines By 16.9%ProPhase Labs, Inc. (NASDAQ:PRPH - Get Free Report) was the target of a significant decrease in short interest in March. As of March 15th, there was short interest totalling 248,200 shares, a decrease of 16.9% from the February 29th total of 298,500 shares. Currently, 1.8% of the company's stock are short sold. Based on an average trading volume of 26,100 shares, the short-interest ratio is currently 9.5 days.March 29, 2024 | marketbeat.comProPhase Labs (NASDAQ:PRPH) Stock Price Crosses Above 200-Day Moving Average of $4.77ProPhase Labs (NASDAQ:PRPH) Shares Cross Above 200-Day Moving Average of $4.77March 21, 2024 | marketbeat.comProPhase Labs, Inc. (NASDAQ:PRPH) Expected to Earn Q1 2024 Earnings of ($0.41) Per ShareProPhase Labs, Inc. (NASDAQ:PRPH - Free Report) - Investment analysts at HC Wainwright reduced their Q1 2024 earnings per share (EPS) estimates for ProPhase Labs in a note issued to investors on Tuesday, March 19th. HC Wainwright analyst Y. Chen now forecasts that the company will earn ($0.41) peMarch 18, 2024 | finance.yahoo.comProPhase Labs, Inc. (NASDAQ:PRPH) Q4 2023 Earnings Call TranscriptMarch 15, 2024 | msn.comPRPH Stock Earnings: ProPhase Labs Misses EPS, Misses Revenue for Q4 2023March 15, 2024 | globenewswire.comProPhase Labs Announces Financial Results for the Year Ended December 31, 2023 and Significant Progress in Its Strategic InitiativesMarch 14, 2024 | benzinga.comProPhase Labs's Earnings: A PreviewMarch 12, 2024 | msn.comDown 34% and 57%, Wall Street Says These 2 Stocks Will Gain 230%March 9, 2024 | marketbeat.comProPhase Labs (PRPH) Scheduled to Post Earnings on FridayProPhase Labs (NASDAQ:PRPH) will be releasing earnings before the market opens on Friday, March 15, Zacks reports.March 8, 2024 | globenewswire.comPROPHASE LABS TO PRESENT 2023 YEAR END FINANCIAL RESULTS ON MARCH 15, 2024March 1, 2024 | finance.yahoo.comProPhase Labs, Inc. (NASDAQ:PRPH) Shares Could Be 29% Above Their Intrinsic Value EstimateFebruary 28, 2024 | marketbeat.comHighTower Advisors LLC Takes $756,000 Position in ProPhase Labs, Inc. (NASDAQ:PRPH)HighTower Advisors LLC acquired a new stake in ProPhase Labs, Inc. (NASDAQ:PRPH - Free Report) during the third quarter, according to its most recent filing with the Securities & Exchange Commission. The firm acquired 173,124 shares of the company's stock, valued at approximately $756,000. HighFebruary 21, 2024 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: Prophase Labs (PRPH) and Crispr Therapeutics AG (CRSP)February 21, 2024 | finance.yahoo.comDiamond Equity Research Releases Update Note on ProPhase Labs Inc. (NASDAQ: PRPH)February 20, 2024 | finance.yahoo.comProPhase Labs Announces Significant Progress in BE-Smart Esophageal Cancer Test Development USPTO grants additional broad patents for BE-SMARTFebruary 20, 2024 | finance.yahoo.comProPhase Labs Announces Significant Progress in BE-Smart Esophageal Cancer Test Development USPTO grants additional broad patents for BE-SMARTFebruary 17, 2024 | marketbeat.comProPhase Labs (NASDAQ:PRPH) Stock Passes Above Two Hundred Day Moving Average of $4.87ProPhase Labs (NASDAQ:PRPH) Shares Pass Above Two Hundred Day Moving Average of $4.87February 16, 2024 | finance.yahoo.comPRPH Mar 2024 5.000 putFebruary 15, 2024 | markets.businessinsider.comBuy Rating for Prophase Labs on Strong Clinical Trial Results and Manufacturing ExpansionFebruary 14, 2024 | finanznachrichten.deProPhase Labs, Inc.: ProPhase Labs Announces Preliminary Positive Results for Dietary Supplement EquivirFebruary 14, 2024 | finance.yahoo.comProPhase Labs Announces Preliminary Positive Results for Dietary Supplement EquivirFebruary 14, 2024 | globenewswire.comProPhase Labs Announces Preliminary Positive Results for Dietary Supplement EquivirFebruary 9, 2024 | marketbeat.comProPhase Labs (NASDAQ:PRPH) Share Price Crosses Above Two Hundred Day Moving Average of $4.94ProPhase Labs (NASDAQ:PRPH) Stock Price Passes Above 200-Day Moving Average of $4.94February 8, 2024 | finance.yahoo.comDiamond Equity Research Releases In Depth Update Note on ProPhase Labs, Inc. (NASDAQ: PRPH) subsidiary, Pharmaloz Manufacturing, Inc. (PMI)January 30, 2024 | baystreet.caProPhase Dips on Moving Karkus up LadderJanuary 30, 2024 | finance.yahoo.comProPhase Labs Ushers in New Genomics Era with Jason Karkus at the Helm of Nebula GenomicsJanuary 23, 2024 | finanznachrichten.deProPhase Labs, Inc.: Pharmaloz Manufacturing Accelerates Expansion, Improves Pricing, Boosts Profitability and Secures New ContractsJanuary 23, 2024 | finance.yahoo.comPharmaloz Manufacturing Accelerates Expansion, Improves Pricing, Boosts Profitability and Secures New ContractsJanuary 13, 2024 | uk.investing.comProPhase Labs Inc (PRPH)January 10, 2024 | msn.comAclaris posts topline data from mid-stage trial for eczema therapy Get ProPhase Labs News Delivered to You Automatically Sign up to receive the latest news and ratings for PRPH and its competitors with MarketBeat's FREE daily newsletter. Email Address This unknown company solves the biggest issue with AI (Ad)Nvidia is the 800-lb gorilla in AI chips. But… it has a big problem. That's where one tiny company comes in. Discover why this company PRPH Media Mentions By Week PRPH Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. PRPH News Sentiment▼0.160.54▲Average Medical News Sentiment PRPH News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. PRPH Articles This Week▼71▲PRPH Articles Average Week Get ProPhase Labs News Delivered to You Automatically Sign up to receive the latest news and ratings for PRPH and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: MIST News Today ANIX News Today ONCY News Today SPRO News Today CMRX News Today BRNS News Today VACC News Today ACRS News Today ETON News Today CLSD News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:PRPH) was last updated on 5/16/2024 by MarketBeat.com Staff From Our PartnersAmazon's betting big on this unknown AI companyManward PressWall Street legend who predicted 2021 tech crash issues new warningChaikin AnalyticsThe #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique WaySmallcaps DailyHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportTop 5 AI Stocks to Buy for 2024Market Moving TrendsTop 5 Tech Stocks to Buy for 2024Daily Market AlertsWith revenue forecasted to grow dramatically in 2024 and beyond, this company should be on your radarStocks NewsShocking $16T Elon Musk Crypto LeakCrypto 101 Media Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ProPhase Labs, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
